The journey dates back to November 2018 when the first ever scientific advisory committee (SAC) on patient blood management was hosted by Werfen India, bringing together the key stakeholders dealing with management of abnormal bleeding. The SAC then had envisioned carrying out a massive campaign on the subject matter.
As a follow up, and to create and expand the market with a value differentiation, a fellowship course in PBM was developed comprising of structured, comprehensive curriculum mentored by world class faculty. More than 100 doctors from anesthesia, transfusion medicine, critical and intensive care, hepatology, obstetrics and trauma specialties participated in the program. More than 85% participants successfully cleared the exit examination to earn the certificate accredited by a prestigious university with a government undertaking.
The key objectives of the program were to generate market advocacy towards implementation of PBM principles. The specific focus on goal directed bleeding management created a pressing need for health technology (viscoelastic testing) adoption.
Having addressed the principles and the practices of patient blood management, this course has provided the expert opinions and recommendations as well as clinical evidences on the ways and means to manage bleeding across different clinical settings, particularly the trauma, obstetric hemorrhages and large organ transplants. The health care practitioners can take forward the learnings from these sessions in redefining the infrastructure and competence needed to manage abnormal bleeding in their institutions.
This is certainly a remarkable milestone achieved by Werfen India and is actually just the beginning and will sure go a long way in establishing the PBM foundation as well as brand identity of Werfen.